Related Experiment Video
Updated: Jul 12, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
The CCL20-CCR6 axis predominantly drives IL-17-mediated psoriasis while modestly contributing to papain-induced type
Supanuch Ekronarongchai1, Nozomi Sachi1, Yomei Kagoshima1
1Department of Infectious Disease Control, Faculty of Medicine, Oita University, Oita, 879-5593, Japan.
The CCL20-CCR6 pathway significantly impacts psoriasis and atopic dermatitis (AD) development. Targeting this axis may offer new treatments for IL-17-driven skin inflammation, especially in psoriasis.
Area of Science:
- Immunology
- Dermatology
- Molecular Biology
Background:
- Chronic inflammatory skin diseases like psoriasis and atopic dermatitis (AD) involve immune system dysregulation.
- The chemokine CCL20 and its receptor CCR6 are elevated in affected skin areas of patients with psoriasis and AD.
Purpose of the Study:
- To investigate the role of the CCL20-CCR6 signaling pathway in the pathogenesis of psoriasis and AD.
- To assess the therapeutic potential of targeting the CCL20-CCR6 axis in these skin conditions.
Main Methods:
- Generation of CCL20- and CCR6-deficient (KO) mice.
- Utilized imiquimod (IMQ)-induced psoriasis model and papain-induced AD model.
- Analyzed clinical scores, cytokine expression (Th17, IL-4), IgE levels, and immune cell infiltration (T cells, mast cells).
Main Results:
- CCL20- and CCR6-KO mice showed reduced disease severity in both IMQ-induced psoriasis and papain-induced AD models compared to wild-type mice.
- In psoriasis models, KO mice exhibited decreased Th17 cytokines and reduced migration of specific T cells.
- In AD models, KO mice displayed reduced type 2 responses, including IL-4 and IgE, with limited impact on other immune cells.
Conclusions:
- The CCL20-CCR6 axis is a major driver of psoriasis pathogenesis, particularly IL-17-driven inflammation.
- The CCL20-CCR6 axis plays a less significant role in papain-induced AD-like inflammation.
- Targeting the CCL20-CCR6 pathway presents a promising therapeutic strategy, especially for psoriasis.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease
The JAK-STAT Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Response I: Vascular and Cellular